Cancer Imaging with Radiolabeled Antibodies: Cancer Treatment and Research, cartea 51
Editat de David M. Goldenbergen Limba Engleză Paperback – 26 sep 2011
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 2078.50 lei 6-8 săpt. | |
Springer Us – 26 sep 2011 | 2078.50 lei 6-8 săpt. | |
Hardback (1) | 2085.72 lei 6-8 săpt. | |
Springer Us – 31 mai 1990 | 2085.72 lei 6-8 săpt. |
Din seria Cancer Treatment and Research
- 5% Preț: 1084.42 lei
- 5% Preț: 714.08 lei
- 5% Preț: 774.32 lei
- 5% Preț: 1020.41 lei
- 5% Preț: 1015.21 lei
- 5% Preț: 1024.17 lei
- 5% Preț: 901.96 lei
- 5% Preț: 706.92 lei
- 5% Preț: 904.65 lei
- 5% Preț: 472.91 lei
- 5% Preț: 651.84 lei
- 5% Preț: 491.35 lei
- 5% Preț: 709.05 lei
- 5% Preț: 364.19 lei
- 15% Preț: 688.31 lei
- 5% Preț: 2081.05 lei
- 5% Preț: 1390.20 lei
- 5% Preț: 1400.11 lei
- 5% Preț: 1088.02 lei
- 5% Preț: 1275.71 lei
- 5% Preț: 1084.62 lei
- 5% Preț: 1075.98 lei
- 5% Preț: 1077.96 lei
- 5% Preț: 1389.70 lei
- 5% Preț: 707.97 lei
- 5% Preț: 694.87 lei
- 5% Preț: 718.76 lei
- 5% Preț: 1390.92 lei
- 5% Preț: 1090.01 lei
- 5% Preț: 1079.60 lei
- 5% Preț: 1073.80 lei
- 5% Preț: 1081.02 lei
- 5% Preț: 1087.66 lei
Preț: 2078.50 lei
Preț vechi: 2187.90 lei
-5% Nou
Puncte Express: 3118
Preț estimativ în valută:
397.97€ • 414.40$ • 330.19£
397.97€ • 414.40$ • 330.19£
Carte tipărită la comandă
Livrare economică 14-28 februarie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9781461288053
ISBN-10: 1461288053
Pagini: 492
Ilustrații: XXII, 468 p.
Dimensiuni: 155 x 235 x 26 mm
Greutate: 0.68 kg
Ediția:Softcover reprint of the original 1st ed. 1990
Editura: Springer Us
Colecția Springer
Seria Cancer Treatment and Research
Locul publicării:New York, NY, United States
ISBN-10: 1461288053
Pagini: 492
Ilustrații: XXII, 468 p.
Dimensiuni: 155 x 235 x 26 mm
Greutate: 0.68 kg
Ediția:Softcover reprint of the original 1st ed. 1990
Editura: Springer Us
Colecția Springer
Seria Cancer Treatment and Research
Locul publicării:New York, NY, United States
Public țintă
ResearchCuprins
I. Historical and Theoretical Perspectives.- 1. Clinical radioimmunodetection: The second decade.- 2. Antibody targeting: Theoretical considerations.- II. Model Systems.- 3. Experimental model systems for antibody targeting and radioimmunodetection.- 4. Preclinical models and methods for the study of radiolabeled monoclonal antibodies in cancer diagnosis and therapy.- 5. Physiology of monoclonal antibody accretion by tumors.- 6. Intraperitoneal delivery of monoclonal antibodies.- III. Radiochemistry.- 7. Chelates and antibodies: Current methods and new directions.- 8. Radiolabeling antibodies via the cyclic anhydride of DTPA — Experiences of 5 years.- 9. Bifunctional chelating agents for radiometal-labeled monoclonal antibodies.- 10. Optimization of biodistribution by introducing different chemical linkages between antibody and an indium-111 chelate.- 11. Novel bifunctional linkers for antibody chelation with radiometals.- 12. Labeling of anti-tumor antibodies and antibody fragments with Tc-9m.- IV. Clinical Studies.- 13. Requirements for the use of radioimmunodetection of cancer in clinical practice.- 14. In-vivo antibody imaging for the detection of human tumors.- 15. In-111 monoclonal antibody immunoscintigraphy of colorectal cancer.- 16. Tumor targeting with monoclonal antibody B72.3: Experimental and clinical results.- 17. Antibody imaging of endocrine tumors.- 18. Diversity of the human immune response to clinically used murine monoclonal antibodies.- V. New Approaches.- 19. Antibody lymphoscintigraphy.- 20. Radioimmunoguided surgery: A new intraoperative approach to the detection of tumor.- 21. Augmentation of tumor antigen expression by recombinant human interferons: Enhanced targeting of monoclonal antibodies to carcinomas.- 22. Anti-antibody enhancement oftumor imaging.
Recenzii
` It is recommended for laboratory investigators who seek detailed information on many of the important issues in radioimmunodetection research and for clinical investigators active in this area, who will benefit from comparing a variety of viewpoints on the major problems that still need to be solved.'
Cancer Cells, 3:1, 1991
Cancer Cells, 3:1, 1991